Courtney Bowling
Nurse Practitioner · Campbellsville, KYNPI 1568960748
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,804 of the $46,649 with a category attached, or 61.7%. AbbVie accounts for 61.4% of it on its own, with 41 other manufacturers making up the rest. 2025 is the largest year on record at $34,932, more than ten times the $3,186 reported in 2021. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 818 payments — averaging $57.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$29K
- Axsome Therapeutics, Inc.$3K
- Pfizer$2K
- Lundbeck LLC$2K
- Biohaven Pharmaceuticals, Inc.$2K
- UCB, Inc.$1K
- plus $8K from 36 others
What the payments were for
- Consulting fees$2,0254%
- Speaking & faculty fees$28,80462%
- Travel & lodging$4161%
- Food & beverage$14,88832%
- Education$5161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,649 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 14 | $314,864 |
| UbrelvyUbrogepant | 164 | $159,000 |
| Nurtec OdtRimegepant Sulfate | 144 | $148,662 |
| Aimovig AutoinjectorErenumab-Aooe | 121 | $115,605 |
| Emgality PenGalcanezumab-Gnlm | 109 | $80,767 |
| QuliptaAtogepant | 39 | $40,860 |
| RexultiBrexpiprazole | 20 | $36,591 |
| XcopriCenobamate | 20 | $22,775 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 18 | $15,582 |
| BriviactBrivaracetam | 11 | $15,218 |
| Memantine Hcl | 345 | $6,866 |
| BrilintaTicagrelor | 13 | $5,763 |
| Levetiracetam | 190 | $5,736 |
| Oxcarbazepine | 67 | $4,211 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 92 | $3,479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $28,644 | $199,860203 claims |
| PfizerNurtec Odt | $1,991 | $148,662144 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $284 | $36,59120 claims |
| SK Life Science, Inc.Xcopri | $465 | $22,77520 claims |
| UCB, Inc.Briviact | $1,433 | $15,21811 claims |
| AstraZenecaBrilinta | $1,025 | $5,76313 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $16 | $1,37122 claims |
| Upsher-smith Laboratories LLCTopiramate | $29 | $1,109141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Campbellsville
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
- Lillian ArgentEdgewood$33K
- Juawanna SchullerLexington$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.